Revenue: The sum of all revenue fields included for a company's operating activities.
CytomX Therapeutics, Inc. (CTMX) had Revenue of $1.42M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$1.42M |
$-20.67M |
|
-- |
|
$1.42M |
|
$25.20M |
|
$-23.78M |
|
$3.17M |
|
$-20.61M |
|
$-20.61M |
|
$-20.67M |
|
$-20.67M |
|
$-20.67M |
|
$-20.67M |
|
$-23.78M |
|
$-25.16M |
|
218.94M |
|
218.94M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$373.15M |
|
$1.08M |
|
$8.07M |
|
$381.23M |
|
$39.86M |
|
-- |
|
$39.30M |
|
$79.16M |
|
$302.07M |
|
$300.75M |
|
$302.07M |
|
217.90M |
|
| Cash Flow Statement Financials | |
$-43.62M |
|
$-186.82M |
|
$235.00M |
|
$14.19M |
|
$18.75M |
|
$4.56M |
|
$7.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1677.08% |
|
-1677.08% |
|
-- |
|
-1453.17% |
|
-1457.40% |
|
$-43.62M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.04 |
|
2379.73 |
|
-6.84% |
|
-6.87% |
|
-5.42% |
|
-6.84% |
|
$1.39 |
|
$-0.20 |
|
$-0.20 |
|